Anti Obesity Medications in Patients With Heart Failure: Current Evidence and Practical Guidance Circulation: Heart Failure Cagrilintide: What It Is and How It's Being Studied for Weight Loss Semaglutide Cagrillintide Blended Peptides for Research & Clinical Trials Oraltide Pharma Efficacy and Safety of Tirzepatide for Weight Management in Non Diabetic Obese Individuals: A Narrative Review Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how